echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > "Symposium on improving bidding and purchasing system of essential drugs" held by China pharmaceutical promotion association and 5 pharmaceutical industry associations

    "Symposium on improving bidding and purchasing system of essential drugs" held by China pharmaceutical promotion association and 5 pharmaceutical industry associations

    • Last Update: 2011-05-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: China Association for the promotion of Drugs May 25, 2011 On the afternoon of May 24, China Pharmaceutical Industry Research and Development Promotion Association (hereinafter referred to as "China pharmaceutical promotion association") held a symposium on "improving the bidding and purchasing system of essential drugs" in Beijing together with five pharmaceutical industry associations, including China Pharmaceutical Enterprise Management Association, China Chemical Pharmaceutical Industry Association, China traditional Chinese Medicine Association, China Pharmaceutical Quality Association and China over the counter drug association The meeting was presided over by song Ruilin, executive chairman of China Pharmaceutical Association More than 60 delegates attended the meeting In addition to the six associations from the conference organizers, the conference representatives also came from Zhejiang Pharmaceutical Industry Association and Shiyao Group Co., Ltd., Tianjin Tianshili Group Co., Ltd., Taiji Group Co., Ltd., Shanghai Fosun Pharmaceutical Group Co., Ltd., Shanghai Pharmaceutical Group Co., Ltd., Zhejiang Kangenbei Pharmaceutical Co., Ltd., Shenwei Pharmaceutical Co., Ltd., North China 16 companies including Pharmaceutical Group Co., Ltd., Northeast Pharmaceutical Group Co., Ltd., Shanxi Zhendong Pharmaceutical Co., Ltd., Beijing Shuanghe Pharmaceutical Co., Ltd., Guangxi Wuzhou Zhongheng Group Co., Ltd., Sichuan Kelun Industrial Co., Ltd., Henan Wanxi Pharmaceutical Co., Ltd., Guangzhou Zhongyi Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Heji Huangpu pharmaceutical Co., Ltd Representatives of domestic pharmaceutical enterprises; journalists from Xinhua news agency, people's daily, people's daily, phoenix.com, economic daily, health daily, pharmaceutical economic daily, 21st century economic report, daily economic news, Caixin media, pharmaceutical manager and other media, as well as from Beijing Qinmai pharmaceutical consulting Co., Ltd and China Pharmaceutical Press Association Of the experts also attended the meeting Participants agreed that the national essential drug system is an important part of deepening the reform of the medical and health system of the CPC Central Committee and the State Council In the past three years, great progress has been made in the implementation of the basic drug system, and the masses have benefited from medical treatment However, there are some problems to be solved in the implementation and cooperation of the basic drug system, especially the bidding and procurement policies Recently, some media reported that some enterprises "win the bid at a low price and can not guarantee the quality" phenomenon has attracted the general attention of all sectors of the society, which must be paid great attention to by all sectors of the society Therefore, it is very necessary and timely for China Council for the promotion of drugs to hold this meeting At the symposium, the representatives mainly reflected on the recent media reports of individual enterprises "winning the bid at a low price and unable to guarantee the quality" and the phenomenon that some local government departments penalize some illegal enterprises in the production and distribution of essential drugs, and discussed how to improve the bidding and procurement system of essential drugs in China to ensure the quality of essential drugs and the safety of people's medication After a heated discussion, the representatives at the meeting basically reached the following consensus: first, the pharmaceutical industry should strengthen self-discipline, establish integrity, regulate operation, produce essential drugs in strict accordance with the requirements of relevant laws, regulations and standards, fulfill social responsibilities with a high sense of responsibility, produce drugs of qualified quality, and ensure the safety of people's medication Second, it is reasonable to implement the "two envelope" system in the bidding of essential drugs The pharmaceutical industry also supports the "two envelope" system However, the relevant departments need to adjust the evaluation index system and the practice of "the lowest bidder wins the bid" in the "two envelope" system, and improve the relevant supporting policies and measures as soon as possible In particular, they should be wary of taking price reduction as the main goal To the only goal, leading to "only low price is to take" Third, the relevant government departments should fully listen to the opinions of the pharmaceutical industry when formulating and revising the policies related to essential drugs, so as to facilitate more scientific decision-making; the pharmaceutical industry association should play an active role in building a bridge between the government departments and enterprises, and serve for the government's decision-making and Industry development Fourth, the pharmaceutical industry is an important support for the reform of China's medical and health system Only a mature, healthy and sustainable pharmaceutical industry can guarantee the national health level of the Chinese nation The interests of pharmaceutical enterprises are consistent with those of the people, the country and the society Fifth, we should explore the establishment of a third-party evaluation mechanism for drug quality as soon as possible, and establish a truly honest social supervision mechanism Venue (I) venue (II)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.